What are the differential diagnoses for a 73‑year‑old post‑menopausal woman with low cortisol, suppressed thyroid‑stimulating hormone, low‑normal free thyroxine and total triiodothyronine, markedly elevated estradiol, low‑normal follicle‑stimulating hormone and luteinizing hormone, and normal prolactin, CA‑125, CEA, inhibin A, inhibin B, alpha‑fetoprotein, and anti‑Müllerian hormone levels?

Differential Diagnosis

This 73-year-old postmenopausal woman most likely has an estrogen-secreting ovarian tumor (granulosa cell tumor or thecoma) causing the markedly elevated estradiol (3301.6 pg/mL), with concurrent primary adrenal insufficiency (cortisol 2.8) and either subclinical hyperthyroidism or non-thyroidal illness affecting thyroid function.

Primary Diagnostic Considerations

1. Estrogen-Secreting Ovarian Tumor (Most Urgent)

• Estradiol of 3301.6 pg/mL is profoundly elevated for a postmenopausal woman (normal postmenopausal range: <20-30 pg/mL), representing a >100-fold increase that cannot be explained by physiologic causes 1.

• Suppressed FSH (3.7) and LH (1.1) in a postmenopausal woman are highly abnormal—these should be elevated (typically >30-40 mIU/mL) but are suppressed here by negative feedback from the massive estradiol excess 1.

• Normal tumor markers (CA-125: 6, inhibin A: 1.1, inhibin B: 3, AFP: 4.2) help exclude malignant germ cell tumors and some epithelial ovarian cancers, but granulosa cell tumors and thecomas often have normal CA-125 1.

• Low AMH (0.029) is expected in postmenopause and does not exclude sex cord-stromal tumors 2.

• Immediate pelvic ultrasound and/or CT/MRI imaging is mandatory to identify an ovarian mass, as these tumors require surgical excision 1.

2. Primary Adrenal Insufficiency (Addison's Disease)

• Cortisol of 2.8 μg/dL is diagnostic of adrenal insufficiency when measured in the morning or during acute illness 3.

• Diagnostic confirmation requires: Paired measurement of serum cortisol and plasma ACTH—ACTH should be markedly elevated (>2-fold upper limit) in primary adrenal insufficiency 3.

• Hyponatremia is present in 90% of newly diagnosed cases, though not reported here; hyperkalaemia occurs in only 50% 3.

• The suppressed TSH (0.018) could be partially explained by adrenal insufficiency, as patients with primary adrenal insufficiency can paradoxically have TSH levels of 4-10 mIU/L due to loss of cortisol's inhibitory effect on TSH, but severe illness can suppress TSH 3.

• Etiologic workup required: Measure 21-hydroxylase (anti-adrenal) autoantibodies first; if negative, obtain CT imaging of adrenals and check very long-chain fatty acids 3.

• This is a medical emergency—treatment with hydrocortisone should never be delayed by diagnostic procedures if acute adrenal crisis is suspected 3.

3. Thyroid Dysfunction (Subclinical Hyperthyroidism vs. Non-Thyroidal Illness)

• TSH of 0.018 mIU/L is profoundly suppressed (normal range: 0.45-4.5 mIU/L), while free T4 (0.930) and total T3 (124) are low-normal 3.

• This pattern suggests either:

  • Subclinical hyperthyroidism from endogenous thyroid disease (Graves' disease, toxic nodular goiter) 3
  • Non-thyroidal illness (euthyroid sick syndrome) from severe underlying disease (adrenal insufficiency, malignancy)—in non-thyroidal illness, TSH is typically subnormal but rarely undetectable (<0.01) unless glucocorticoids or dopamine are administered 3
  • Exogenous thyroid hormone suppression from the massive estradiol excess affecting thyroid hormone metabolism 4

• Key distinguishing feature: In non-thyroidal illness, free T4 is typically in the lower part of the normal range (as seen here), whereas in subclinical hyperthyroidism, free T4 is typically high-normal 3.

• The combination of severe adrenal insufficiency and possible ovarian malignancy makes non-thyroidal illness more likely than primary thyroid disease 3.

• Thyroid disease is common in postmenopausal women (23.2% have subclinical thyroid disease), but the clinical context here points away from primary thyroid pathology 4, 5.

Clinical Pitfalls and Caveats

Critical Timing Issues

• Do not delay treatment of suspected adrenal crisis to complete diagnostic workup—if clinically unstable, administer hydrocortisone 100 mg IV immediately, then draw ACTH and cortisol 3.

• The ovarian tumor requires urgent surgical evaluation as these can undergo torsion, rupture, or represent malignancy 1.

Diagnostic Sequence

1. Obtain plasma ACTH immediately (before giving hydrocortisone if patient is stable) to confirm primary vs. secondary adrenal insufficiency 3.

2. Order pelvic imaging (transvaginal ultrasound, CT, or MRI) to identify the estrogen-secreting tumor 1.

3. Measure thyroid antibodies (TPO-Ab, TSH receptor antibodies) and consider thyroid ultrasound to differentiate primary thyroid disease from non-thyroidal illness 5.

4. Check 21-hydroxylase antibodies to determine autoimmune etiology of adrenal insufficiency 3.

Hormone Interactions

• Estrogen excess increases thyroxine-binding globulin (TBG), which can alter thyroid function tests and increase thyroxine requirements if the patient later needs thyroid hormone replacement 4.

• Glucocorticoid administration (for adrenal insufficiency) can suppress TSH, confounding thyroid function assessment—wait until glucocorticoid replacement is stable before reassessing thyroid status 3.

• Hyperthyroidism (if present) increases cardiovascular risk in postmenopausal women, with increased cardiovascular mortality (HR 3.3) when TSH is suppressed 6.

Immediate Management Priorities

• Assess for acute adrenal crisis: Check electrolytes (sodium, potassium), blood pressure, and clinical signs of shock 3.

• Initiate stress-dose hydrocortisone (100 mg IV q8h) if acute illness is present, then taper to maintenance dosing (15-25 mg daily in divided doses) 3.

• Arrange urgent gynecologic oncology consultation for evaluation and surgical planning of suspected ovarian tumor 1.

• Provide patient education and emergency supplies: Medic Alert identification, steroid card, and self-injection supplies for parenteral hydrocortisone 3.